Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

Bispecific Antibody Pretargeting PET (ImmunoPET) with an 124I-Labeled Hapten-Peptide

William J. McBride, Pat Zanzonico, Robert M. Sharkey, Carl Norén, Habibe Karacay, Edmund A. Rossi, Michele J. Losman, Pierre-Yves Brard, Chien-Hsing Chang, Steven M. Larson and David M. Goldenberg
Journal of Nuclear Medicine October 2006, 47 (10) 1678-1688;
William J. McBride
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pat Zanzonico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert M. Sharkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl Norén
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Habibe Karacay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edmund A. Rossi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michele J. Losman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre-Yves Brard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chien-Hsing Chang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven M. Larson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David M. Goldenberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 47 no. 10 1678-1688
PubMed 
17015905

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication February 2, 2006
  • Accepted for publication July 17, 2006
  • Published online October 2, 2006.

Copyright & Usage 
© 2006 by Society of Nuclear Medicine

Author Information

  1. William J. McBride 1 ,
  2. Pat Zanzonico 2 ,
  3. Robert M. Sharkey 3 ,
  4. Carl Norén 1 ,
  5. Habibe Karacay 3 ,
  6. Edmund A. Rossi 4 ,
  7. Michele J. Losman 1 ,
  8. Pierre-Yves Brard 3 ,
  9. Chien-Hsing Chang 1 , 4 ,
  10. Steven M. Larson 5 and
  11. David M. Goldenberg 1 , 3 , 4
  1. 1Immunomedics, Inc., Morris Plains, New Jersey; 2Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York; 3Center for Molecular Medicine and Immunology, Belleville, New Jersey; 4IBC Pharmaceuticals, Inc., Morris Plains, New Jersey; and 5Nuclear Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York
  1. For correspondence or reprints contact: Robert M. Sharkey, PhD, Center for Molecular Medicine and Immunology, 520 Belleville Ave, Belleville, NJ 07109. E-mail: rmsharkey{at}gscancer.org.
View Full Text

Statistics from Altmetric.com

Cited By...

  • 92 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: October 2006 to April 2025

AbstractFullPdf
Oct 200615238103
Nov 2006313750
Dec 2006161522
Jan 2007292021
Feb 2007352123
Mar 2007232532
Apr 2007182021
May 2007122115
Jun 2007132923
Jul 2007221611
Aug 200771614
Sep 200791013
Oct 2007103028
Nov 200732518
Dec 2007264638
Jan 200862929
Feb 200851214
Mar 2008193234
Apr 200883332
May 2008153533
Jun 2008194326
Jul 2008222821
Aug 2008244918
Sep 2008172824
Oct 2008152419
Nov 2008172417
Dec 2008132210
Jan 2009192217
Feb 2009111816
Mar 200916189
Apr 2009122717
May 2009171513
Jun 2009122512
Jul 2009162813
Aug 2009142418
Sep 200982020
Oct 2009492016
Nov 2009471711
Dec 200912149
Jan 201012168
Feb 20109812
Mar 20107278
Apr 201017197
May 2010242215
Jun 2010171912
Jul 20109149
Aug 201037159
Sep 20109117
Oct 20106118
Nov 2010131711
Dec 2010101312
Jan 2011121411
Feb 20119159
Mar 2011111012
Apr 201121812
May 201192111
Jun 2011231620
Jul 201115148
Aug 201112139
Sep 2011202552
Oct 2011151019
Nov 2011161014
Dec 201112155
Jan 201226109
Feb 2012202211
Mar 2012313729
Apr 2012372010
May 2012153417
Jun 201210119
Jul 2012181412
Aug 2012211112
Sep 2012201410
Oct 2012233233
Nov 2012182018
Dec 201223149
Jan 2013302315
Feb 2013192516
Mar 2013242113
Apr 201313168
May 2013262312
Jun 2013151911
Jul 2013111313
Aug 2013161814
Sep 201373121
Oct 201310108
Nov 20135912
Dec 201317176
Jan 20148127
Feb 2014171417
Mar 2014111210
Apr 2014161811
May 2014131212
Jun 20141053
Jul 20141098
Aug 2014887
Sep 201416711
Oct 20141499
Nov 201412813
Dec 201410711
Jan 201516107
Feb 201516135
Mar 201525258
Apr 201520143
May 201534104
Jun 20151183
Jul 2015261918
Aug 201510137
Sep 201514166
Oct 20151132
Nov 201521237
Dec 201552193
Jan 201642129
Feb 201634125
Mar 201617611
Apr 201624104
May 20162593
Jun 20168208
Jul 2016151924
Aug 201671713
Sep 2016111217
Oct 2016112215
Nov 201661811
Dec 20162161
Jan 201713236
Feb 20178261
Mar 2017222012
Apr 201713215
May 201710249
Jun 20179231
Jul 20178133
Aug 2017101312
Sep 20175122
Oct 20177144
Nov 201710218
Dec 201710377
Jan 20182325
Feb 201882111
Mar 201872717
Apr 201852510
May 201820294
Jun 20189302
Jul 201813221
Aug 20183131
Sep 20188268
Oct 201813568
Nov 2018244012
Dec 201816576
Jan 201918407
Feb 201923463
Mar 201927392
Apr 201921416
May 20193172
Jun 20196124
Jul 2019121910
Aug 201913187
Sep 201931110
Oct 2019243
Nov 20193151
Dec 20192178
Jan 2020695
Feb 2020661
Mar 2020694
Apr 2020177
May 20202166
Jun 2020043
Jul 2020492
Aug 20203622
Sep 2020596
Oct 20207147
Nov 202071711
Dec 20208103
Jan 20216156
Feb 20213218
Mar 2021122610
Apr 202132516
May 20219137
Jun 202114522
Jul 20214277
Aug 20213174
Sep 20212196
Oct 20214102
Nov 2021101511
Dec 20218206
Jan 20229168
Feb 20226135
Mar 20224206
Apr 2022174
May 20225149
Jun 20225145
Jul 20224143
Aug 2022164
Sep 20222163
Oct 20222174
Nov 2022293
Dec 20223141
Jan 2023102421
Feb 20232193
Mar 202355412
Apr 20232187
May 20231176
Jun 20232256
Jul 202371711
Aug 2023066
Sep 20232243
Oct 20233147
Nov 20233153
Dec 20231433
Jan 202410192
Feb 202424192
Mar 20241188
Apr 20243534
May 202410336
Jun 202473412
Jul 20243226
Aug 20246619
Sep 20244316
Oct 202462413
Nov 202412238
Dec 202424110
Jan 20253257
Feb 20257899
Mar 20257396
Apr 20250427
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 47 (10)
Journal of Nuclear Medicine
Vol. 47, Issue 10
October 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bispecific Antibody Pretargeting PET (ImmunoPET) with an 124I-Labeled Hapten-Peptide
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Bispecific Antibody Pretargeting PET (ImmunoPET) with an 124I-Labeled Hapten-Peptide
William J. McBride, Pat Zanzonico, Robert M. Sharkey, Carl Norén, Habibe Karacay, Edmund A. Rossi, Michele J. Losman, Pierre-Yves Brard, Chien-Hsing Chang, Steven M. Larson, David M. Goldenberg
Journal of Nuclear Medicine Oct 2006, 47 (10) 1678-1688;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Bispecific Antibody Pretargeting PET (ImmunoPET) with an 124I-Labeled Hapten-Peptide
William J. McBride, Pat Zanzonico, Robert M. Sharkey, Carl Norén, Habibe Karacay, Edmund A. Rossi, Michele J. Losman, Pierre-Yves Brard, Chien-Hsing Chang, Steven M. Larson, David M. Goldenberg
Journal of Nuclear Medicine Oct 2006, 47 (10) 1678-1688;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Pretargeting: A Path Forward for Radioimmunotherapy
  • {alpha}- Versus {beta}-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts
  • Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial
  • Diels-Alder Reaction for Tumor Pretargeting: In Vivo Chemistry Can Boost Tumor Radiation Dose Compared with Directly Labeled Antibody
  • Quantitative Immuno-SPECT Monitoring of Pretargeted Radioimmunotherapy with a Bispecific Antibody in an Intraperitoneal Nude Mouse Model of Human Colon Cancer
  • Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement
  • Immuno-PET of Cancer: A Revival of Antibody Imaging
  • Optimization of Hapten-Peptide Labeling for Pretargeted ImmunoPET of Bispecific Antibody Using Generator-Produced 68Ga
  • Pretargeted 177Lu Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colonic Tumors in Mice
  • Pretargeted Immuno-Positron Emission Tomography Imaging of Carcinoembryonic Antigen-Expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts
  • Pretargeted Radioimmunotherapy of Pancreatic Cancer Xenografts: TF10-90Y-IMP-288 Alone and Combined with Gemcitabine
  • CD20-targeted tetrameric interferon-{alpha}, a novel and potent immunocytokine for the therapy of B-cell lymphomas
  • A Novel Method of 18F Radiolabeling for PET
  • Improved Therapeutic Results by Pretargeted Radioimmunotherapy of Non-Hodgkin's Lymphoma with a New Recombinant, Trivalent, Anti-CD20, Bispecific Antibody
  • A Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic Carcinoma
  • Multifunctional Antibodies by the Dock-and-Lock Method for Improved Cancer Imaging and Therapy by Pretargeting
  • Bispecific Antibody Pretargeting of Radionuclides for Immuno-Single-Photon Emission Computed Tomography and Immuno-Positron Emission Tomography Molecular Imaging: An Update
  • Google Scholar

More in this TOC Section

  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
  • Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
  • Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire